4 Worst High Blood Pressure Medicines

Ascot-lla (anglo-scandinavian cardiac outcomes trial–lipid lowering arm) was designed to assess the benefits of atorvastatin (lipitor) versus a placebo in patients who had high blood pressure with average or lower-than-average cholesterol concentrations and at least three other cardiovascular risk factors. 50 the trial was originally planned.